Stockscreener 앱 받기
6.85
2.00%
-0.14
시간 외 거래:
6.85
전일 마감가:
$6.99
열려 있는:
$6.99
하루 거래량:
5,961
Relative Volume:
0.26
시가총액:
$27.73M
수익:
$6.44M
순이익/손실:
$-58.21M
주가수익비율:
0.2191
EPS:
31.2684
순현금흐름:
$-4.86M
1주 성능:
+0.74%
1개월 성능:
-4.06%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$6.85
$7.0721
1주일 범위
$6.8201
$7.0721
52주 변동 폭
$6.32
$9.58
Kyntra Bio Inc Stock (KYNB) Company Profile
명칭
Kyntra Bio Inc
전화
415-978-1200
주소
350 BAY STREET, SAN FRANCISCO
Compare KYNB vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KYNB
Kyntra Bio Inc
|
6.85 | 28.30M | 6.44M | -58.21M | -4.86M | 31.27 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kyntra Bio Inc Stock (KYNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-26 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-06-26 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | 업그레이드 | Stifel | Hold → Buy |
| 2023-01-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-09-22 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-20 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-07-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-04-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-03-31 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-02-01 | 개시 | H.C. Wainwright | Buy |
| 2020-10-26 | 개시 | Raymond James | Underperform |
| 2020-07-10 | 재개 | Stifel | Buy |
모두보기
Kyntra Bio Inc 주식(KYNB)의 최신 뉴스
KYNB Stock Price, Quote & Chart | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill
KYNB Technical Analysis | Trend, Signals & Chart Patterns | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill
Kyntra Bio CEO Thane Wettig buys $19,852 in stock - Investing.com India
Kyntra Bio CEO Thane Wettig buys $19,852 in stock By Investing.com - Investing.com Australia
KYNTRA BIO (KYNB) CEO Thane Wettig adds 2,800 shares in open-market buy - Stock Titan
What's Next for Kyntra Bio (KYNB) at $6.80? 2026-05-19Growth Picks - Newser
Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale - TipRanks
Kyntra Bio CEO Thane Wettig buys $19,852 in company stock By Investing.com - Investing.com Australia
Kyntra Bio CEO Thane Wettig buys $19,852 in company stock - Investing.com India
KYNTRA BIO (KYNB) CEO Thane Wettig purchases 2,800 shares at $7.09 - Stock Titan
Kyntra Bio (KYNB) Q1 2026 Earnings Transcript - AOL.com
Armistice Capital (FGEN) reports 400,000-share, 9.88% position (May 2026) - Stock Titan
Kyntra Bio (KYNB) Institutional Ownership 2026 - MarketBeat
Number of shareholders of Kyntra Bio, Inc. – NASDAQ:KYNB - TradingView
Number of shareholders of Kyntra Bio, Inc. – LSE:0IL8 - TradingView
Kyntra Bio (Nasdaq: KYNB) Q1 2026 results show higher revenue, ongoing R&D spend - Stock Titan
Kyntra Bio stock (US3156631046): Q1 2026 revenue rises to $3.7M amid pipeline advances - AD HOC NEWS
Kyntra Bio Inc. (KYNB) News, Articles, Events & Latest Updates - Stocktwits
Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances Amidst Challenges - GuruFocus
Kyntra Bio targets Q4 2026 interim readout while extending cash runway into 2028 - MSN
Kyntra Bio (KYNB) reports Q1 loss, tops revenue estimates - MSN
Kyntra Bio, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:KYNB) 2026-05-11 - Seeking Alpha
KYNB: Revenue rose, expenses fell, and clinical milestones remain on track with cash runway into 2028 - TradingView
Is Kyntra Bio (KYNB) 31.3% Overvalued After Q1 2026 Earnings Bea - GuruFocus
KYNB: Revenue up, losses narrowed, and key clinical programs advancing with strong cash position - TradingView
Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Kyntra Bio (NASDAQ:KYNB) Q1 Revenue Surges 180% as EPS Miss Tempers After-Hours Gains - ChartMill
Kyntra Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Kyntra Bio: Q1 Earnings Snapshot - 10TV
Kyntra Bio : Reports First Quarter 2026 Financial Results - marketscreener.com
KYNB: Q1 2026 revenue rose to $3.7M, net loss narrowed, and key clinical trials advanced - TradingView
Kyntra Bio (NASDAQ: FGEN) Q1 2026 results, oncology pipeline and cash runway - Stock Titan
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update - Yahoo! Finance Canada
MSN Money - MSN
Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances ... By GuruFocus - Investing.com Canada
Kyntra Bio Inc expected to post a loss of $3.35 a shareEarnings Preview - TradingView
Kyntra Bio (KYNB) upgraded to buy: Here's what you should know - MSN
Earnings Preview: Kyntra Bio to Report Financial Results Post-market on May 11 - 富途牛牛
Kyntra Bio sets May 11 Q1 results release, 5 p.m. investor call - Stock Titan
Kyntra Bio to Report First Quarter 2026 Financial Results - GlobeNewswire
Kyntra Bio to report Q1 2026 financial results and host investor call on May 11 - Pluang
William Blair Maintains KYNTRA BIO INC(KYNB.US) With Hold Rating - 富途牛牛
Kyntra Bio Inc (KYNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kyntra Bio Inc 주식 (KYNB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO |
Nov 13 '25 |
Buy |
9.18 |
1,000 |
9,180 |
22,239 |
| Schoeneck James A | Director |
Jun 30 '25 |
Buy |
5.07 |
23,567 |
119,485 |
39,666 |
0.98%
0.12%
자본화:
|
볼륨(24시간):